Adial Pharmaceuticals Inc... (ADIL)
0.75
-0.04 (-4.46%)
At close: Mar 03, 2025, 3:59 PM
0.73
-2.19%
After-hours: Mar 03, 2025, 05:32 PM EST
Adial Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 564.00 | 60.5K | 55.11K | 564.00 | 565.00 | 563.00 | 565.00 | 565.00 | 565.00 |
| Gross Profit | -564 | -60.5K | -55.11K | -564 | -565 | -563 | -565 | -565 | -565 |
| Operating Income | -6.89M | -13.32M | -19.29M | -10.93M | -8.24M | -6.99M | -995.29K | -410.81K | -819.26K |
| Interest Income | 69.78K | 63.34K | 6.54K | 32.49K | 95.23K | 7.39K | 367.00 | 240.00 | 1.26K |
| Pretax Income | -7M | -12.73M | -19.52M | -10.89M | -8.59M | -11.63M | -1.14M | -420.2K | -817.99K |
| Net Income | -7M | -12.73M | -19.42M | -10.86M | -8.59M | -11.63M | -1.14M | -420.2K | -817.99K |
| Selling & General & Admin | 5.62M | 9.14M | 9.34M | 5.07M | 4.28M | 6.62M | 813.18K | 264.66K | 497.15K |
| Research & Development | 1.27M | 4.18M | 8.4M | 5.85M | 3.97M | 368.46K | 182.11K | 146.14K | 322.11K |
| Other Expenses | n/a | n/a | 46.49K | 2.5K | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 6.89M | 13.32M | 17.74M | 10.93M | 8.24M | 6.99M | 995.29K | 410.81K | 819.26K |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.17M | 144.54K | 9.64K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 6.89M | 13.32M | 17.74M | 10.93M | 8.24M | 6.99M | 995.29K | 410.81K | 819.26K |
| Income Tax | n/a | -502 | -94.08K | -32.49K | -76.06K | -3.48M | 367.00 | 9.64K | 1.26K |
| Shares Outstanding (Basic) | 1.42M | 1.06M | 743.55K | 498.52K | 394.1K | 190.37K | 218.99K | 191.13K | 191.28K |
| Shares Outstanding (Diluted) | 1.42M | 1.06M | 743.55K | 498.52K | 394.1K | 190.37K | 218.99K | 191.13K | 191.28K |
| EPS (Basic) | -5.44 | -11.98 | -26.12 | -21.79 | -21.8 | -61.1 | -5.2 | -2.2 | -4.28 |
| EPS (Diluted) | -5.44 | -11.98 | -26.12 | -21.79 | -21.8 | -61.1 | -5.2 | -2.2 | -4.28 |
| EBITDA | -7M | -13.32M | -19.46M | -10.93M | -8.15M | -6.98M | -994.35K | -410K | -817.43K |
| Depreciation & Amortization | 564.00 | 564.00 | 55.11K | 564.00 | 565.00 | 563.00 | 565.00 | 565.00 | 565.00 |